Hostname: page-component-7479d7b7d-767nl Total loading time: 0 Render date: 2024-07-11T11:19:46.974Z Has data issue: false hasContentIssue false

Agitation in the patient with dual pathology

Published online by Cambridge University Press:  23 March 2020

L. Hernández Plaza*
Affiliation:
Hospital Ramon y Cajal, Psiquiatría, Madrid, Spain
M. García Navarro
Affiliation:
Complejo hospitalario de Cáceres, Psiquiatría, Caceres, Spain
E. Delgado Parada
Affiliation:
Hospital Ramon y Cajal, Psiquiatría, Madrid, Spain
E. Ochoa Mangado
Affiliation:
Hospital Ramon y Cajal, Psiquiatría, Madrid, Spain
E. Salvador Vadillo
Affiliation:
Hospital Ramon y Cajal, Psiquiatría, Madrid, Spain
S. Molins Pascual
Affiliation:
Hospital Ramon y Cajal, Psiquiatría, Madrid, Spain
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

The consumption of toxic substances often causes agitation, which makes more difficult the pharmacological management of the symptoms.

Objective

About one case, a search was performed of the different therapeutic options in the agitation takes place in the context of intoxication.

Methods

Thirty-five-year-old male patient diagnosed of dual pathology under treatment since 2003 in our outpatient. The patient shows paranoid schizophrenia disorder due to alcohol, cannabis and cocaine use disorder, summing up different pharmacological treatments with no remission. Whilst the examination is taking place the patient is under alcohol and cannabis effects. His physical and verbal behaviour are aggressive showing psychotic instability. The therapeutic team administers loxapine to its patient.

Results

The inhaled loxapine turned out to be a good alternative in the case given.

Conclusion

Handling agitation when toxics are involved is complex. The new formulation of inhaled loxapine helps to control agitation quickly and it might be a feasible option for this kind of patients.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EW125
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.